CellOrigin
is headquartered in Hangzhou, Zhejiang Province. Jiansong Tong is the Co-Founder & CEO of CellOrigin. CellOrigin has raised a total of $15.7M in funding. CellOrigin has 1 followers on Owler.CellOrigin
is headquartered in Hangzhou, Zhejiang Province. Jiansong Tong is the Co-Founder & CEO of CellOrigin. CellOrigin has raised a total of $15.7M in funding. CellOrigin has 1 followers on Owler.
News
Jan 05, 2025
Pharamceutical Technology
CellOrigin: SY-001 by CellOrigin Technology (Hangzhou) for Pancreatic Cancer: Likelihood of Approval
Dec 20, 2023
PR Newswire
Press Release: CellOrigin : CellOrigin announced treatment of the first patient with CAR-M in China and reported the second generation of CAR-M for solid tumors
Sep 27, 2022
Pharmabiz
CellOrigin: CellOrigin Biotech collaborates with Qilu Pharma to develop "offtheshelf" CARiMAC cell therapy
Mar 31, 2022
Biospectrum Asia
CellOrigin: CellOrigin raises new funds to Jump-start iPSC immune cell therapy products toward clinics
Oct 15, 2021
Markets Insider
CellOrigin: CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform